Jean Tessier

1.9k total citations
46 papers, 1.5k citations indexed

About

Jean Tessier is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Jean Tessier has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Jean Tessier's work include Advanced MRI Techniques and Applications (17 papers), MRI in cancer diagnosis (15 papers) and Radiomics and Machine Learning in Medical Imaging (9 papers). Jean Tessier is often cited by papers focused on Advanced MRI Techniques and Applications (17 papers), MRI in cancer diagnosis (15 papers) and Radiomics and Machine Learning in Medical Imaging (9 papers). Jean Tessier collaborates with scholars based in United Kingdom, Switzerland and France. Jean Tessier's co-authors include K. J. Packer, John C. Waterton, D. Checkley, Stephen R. Wedge, Jane Kendrew, Alan Jackson, Xiaoping Zhu, Jean‐François Thovert, P. M. Adler and Françoise Kraeber‐Bodéré and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Radiology.

In The Last Decade

Jean Tessier

46 papers receiving 1.4k citations

Peers

Countries citing papers authored by Jean Tessier

Since Specialization

Citations

This map shows the geographic impact of Jean Tessier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Tessier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Tessier more than expected).

Fields of papers citing papers by Jean Tessier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Tessier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Tessier. The network helps show where Jean Tessier may publish in the future.

Co-authorship network of co-authors of Jean Tessier

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Tessier. A scholar is included among the top collaborators of Jean Tessier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Tessier. Jean Tessier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prediction of the Optimal Dosing Regimen Using a Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy 2018 ·Clinical Cancer Research ·Benjamin Ribba, Christophe Boetsch, Tapan K. Nayak, Hans Peter Grimm, Jehad Charo, Stefan Evers, Christian Klein, Jean Tessier, (unknown), Alex Phipps, Pavel Pisa, Volker Teichgräber	56
2	An apparent clinical pharmacokinetic drug–drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanism 2017 ·Cancer Chemotherapy and Pharmacology ·Ka Wang, (unknown), Tilman Schlothauer, Angelika Lahr, Valérie Cosson, Jianguo Zhi, Kai Habben, Jean Tessier, Eginhard Schick, Roland F. Staack, Oliver Krieter	8
3	Quantitative computed tomography determined regional lung mechanics in normal nonsmokers, normal smokers and metastatic sarcoma subjects 2017 ·PLoS ONE ·Jiwoong Choi, Eric A. Hoffman, Ching‐Long Lin, Mohammed Milhem, Jean Tessier, John D. Newell	7
4	Diffusion-weighted MR imaging of metastatic abdominal and pelvic tumours is sensitive to early changes induced by a VEGF inhibitor using alternative diffusion attenuation models 2015 ·European Radiology ·Matthew Orton, Christina Messiou, David J. Collins, Veronica A. Morgan, Jean Tessier, Helen Young, Nandita M. deSouza, Martin O. Leach	33
5	Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with RAS–RAF Mutations 2014 ·Clinical Cancer Research ·Lisa Zimmer, Fabrice Barlési, Maria Martinez‐García, Véronique Dièras, Jan H.M. Schellens, Jean‐Philippe Spano, Mark R. Middleton, Emiliano Calvo, L. Paz-Ares, James Larkin, Simon Pacey, Miro Venturi, Françoise Kraeber‐Bodéré, Jean Tessier, Wilfried Eberhardt, Michel Pâques, Ernesto Guarin, Valérie Méresse, Jean‐Charles Soria	59
6	Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [18F] FDG-PET imaging combined with proteomic approaches 2014 ·EJNMMI Research ·(unknown), (unknown), (unknown), Nobuya Ishii, Satoshi Aida, Yasushi Yoshimura, Chia-Huey Ooi, Frank Leigh Lu, Nicholas Mitsios, Valérie Méresse, Jan Mulder, Michael Pawlak, Miro Venturi, Jean Tessier, Sharon Stone‐Elander	7
7	Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the MEK Inhibitor RO4987655 (CH4987655) in Patients with Advanced Solid Tumors 2012 ·Clinical Cancer Research ·Suzanne Leijen, Mark R. Middleton, Patricia Tresca, Françoise Kraeber‐Bodéré, Véronique Dièras, M. E. Scheulen, Avinash Gupta, Vanesa López-Valverde, Zhixin Xu, Ruediger Rueger, Jean Tessier, Eliezer Shochat, (unknown), (unknown), Jan H.M. Schellens, Wilfried Eberhardt	55
8	First-in-Human, Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of RO5126766, a First-in-Class Dual MEK/RAF Inhibitor in Patients with Solid Tumors 2012 ·Clinical Cancer Research ·Maria Martinez‐García, Udai Banerji, Joan Albanell, Rastilav Bahleda, Saoirse Dolly, Françoise Kraeber‐Bodéré, Federico Rojo, Émilie Routier, Ernesto Guarin, Zhixin Xu, Ruediger Rueger, Jean Tessier, Eliezer Shochat, (unknown), (unknown), Jean‐Charles Soria	122
9	A two-part Phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics 2010 ·Cancer Chemotherapy and Pharmacology ·Claire L. Mitchell, James P.B. O’Connor, Caleb Roberts, Y. Watson, Alan Jackson, Susan Cheung, Jeffrey Evans, James Spicer, Adrian L. Harris, (unknown), (unknown), Mark R. Middleton, Anitra Fielding, Jean Tessier, Helen Young, Geoff J.M. Parker, Gordon C. Jayson	19
10	DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study 2009 ·PubMed ·K. Mross, Ulrike Fasol, Annette Frost, (unknown), Jan Kuhlmann, Martin Büchert, Clemens Unger, Hubert E. Blum, Jürgen Hennig, Tsveta Milenkova, Jean Tessier, Annetta Krebs, Anderson J. Ryan, Richard Fischer	41
11	Examining the acute effects of cediranib (RECENTIN, AZD2171) treatment in tumor models: a dynamic contrast-enhanced MRI study using gadopentate 2008 ·Magnetic Resonance Imaging ·Daniel P. Bradley, Jean Tessier, (unknown), Marietta Scott, Juliane M. Jürgensmeier, Rajesh Odedra, (unknown), (unknown), Stephen R. Wedge	33
12	What levels of precision are achievable for quantification of perfusion and capillary permeability surface area product using ASL? 2007 ·Magnetic Resonance in Medicine ·(unknown), David L. Buckley, Jean Tessier, Geoff J.M. Parker	31
13	Misregistration artifacts in image‐derived arterial input function in non‐echo‐planar imaging‐based dynamic contrast‐enhanced MRI 2007 ·Journal of Magnetic Resonance Imaging ·(unknown), Philip Worthington, Daniel P. Bradley, D. Checkley, Jean Tessier, John C. Waterton	2
14	Averaging Keyhole Pulse Sequence with Presaturation Pulses and EXORCYCLE Phase Cycling for Dynamic Contrast-Enhanced MRI 2004 ·Magnetic Resonance in Medical Sciences ·(unknown), Daniel P. Bradley, D. Checkley, Philip Worthington, Jean Tessier	4
15	Effective blood signal suppression using double inversion‐recovery and slice reordering for multislice fast spin‐echo MRI and its application in simultaneous proton density and T₂ weighted imaging 2004 ·Journal of Magnetic Resonance Imaging ·(unknown), Jean Tessier, D. Checkley, Yì Wáng, Leif Hultin, John C. Waterton	11
16	Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma 2003 ·British Journal of Radiology ·Alan Jackson, Gordon C. Jayson, (unknown), Xiaoping Zhu, D. Checkley, Jean Tessier, John C. Waterton	104
17	Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data 2003 ·British Journal of Radiology ·(unknown), Xiaoping Zhu, D. Checkley, Jean Tessier, (unknown), John C. Waterton, Alan Jackson	54
18	Characterisation of the guinea pig model of osteoarthritis by in vivo three-dimensional magnetic resonance imaging 2003 ·Osteoarthritis and Cartilage ·Jean Tessier, Jonathan Bowyer, (unknown), Ian Peers, F. Russell Westwood, John C. Waterton, Rose A. Maciewicz	64
19	Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours 2003 ·British Journal of Cancer ·D. Checkley, Jean Tessier, Jane Kendrew, John C. Waterton, Stephen R. Wedge	102
20	The characterisation of fluid transport in porous solids by means of pulsed magnetic field gradient NMR 1998 ·Magnetic Resonance Imaging ·K. J. Packer, Siegfried Stapf, Jean Tessier, Robin A. Damion	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact